Wednesday, July 18, 2007 3:39:24 PM
"I think the line "*Encapsulated islet cells incorporate technology from Novocell, Inc. and SurModics" may be more telling."
Perhaps, but its so vague it could refer to the islet cell encapsulation per se rather than general cellular encapsulation with the technology they are using, the "CELLabration Cell Encapsulation System". SRDX's patents pertain to the use of crosslinkable macromers (including PEG) bearing initiator groups (UV activated) and polymerizable groups, which it is claimed has advantages over the use of seperate, low molecular weight initiators. They refer to this as a "crosslinkable macromer system". My guess is that this is SRDX's "CELLabration System".
Perhaps, but its so vague it could refer to the islet cell encapsulation per se rather than general cellular encapsulation with the technology they are using, the "CELLabration Cell Encapsulation System". SRDX's patents pertain to the use of crosslinkable macromers (including PEG) bearing initiator groups (UV activated) and polymerizable groups, which it is claimed has advantages over the use of seperate, low molecular weight initiators. They refer to this as a "crosslinkable macromer system". My guess is that this is SRDX's "CELLabration System".
The obstacle to discovery is the illusion of knowledge.
Recent SRDX News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/21/2025 05:15:02 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 11:16:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 11:15:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 11:14:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 11:13:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 11:11:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 11:10:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 11:08:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 11:06:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 11:04:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 11:03:24 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 11/19/2025 09:48:05 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 11/19/2025 09:32:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/19/2025 09:30:15 PM
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 11/19/2025 02:47:33 PM
